Pacific Biosciences of California, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Pacific Biosciences of California, Inc. (PACB) had Deferred Tax Assets, Operating Loss Carryforwards of $466.00 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $466.00M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $434.12M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $435.49M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $400.63M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $466.00M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $434.12M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $435.49M 10-K · filed 2025-03-17 | |
| 2022-12-31 | $400.63M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $378.04M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $233.22M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $226.91M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $212.42M 10-K · filed 2020-02-28 | |
| 2017-12-31 | $194.44M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $264.18M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $235.66M 10-K · filed 2017-03-06 | |
| 2014-12-31 | $225.12M 10-K · filed 2016-03-11 | |
| 2013-12-31 | $214.31M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $187.40M 10-K · filed 2014-03-14 | $186.91M 10-K · filed 2013-03-15 |
| 2011-12-31 | $154.12M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |